|
Friday 14th February 2003 |
Text too small? |
Even so the dental and medical software maker's revenues are growing fast and it will no doubt come back into fashion once it shows it can keep costs in check and pump out earnings at the bottom line.
The shares were listed in December 2000 after a float at $1. The prospectus forecast March 2002-year revenue of $14.6 million and a $2.4 million net profit. It didn't make either; revenue was only slightly off at $13.7 million but it lost $191,000.
The company is picking a breakeven result for the March 2003 year after losing $1.43 million in the first half.
Following the $2.5 million acquisition of Advanced Healthcare Computing, Britain now accounts for more than 83% of group revenues. The company is also on a major sales push into the US, with modest results so far, and its dental software is in use in Australia, Singapore, Malaysia, Ireland, Kuwait, Saudi Arabia and Dubai.
It has also moved into the optometry software market with a contract to supply the local Visique chain.
A November rights issue aimed at raising $6.2 million brought in only $4.3 million but the company is debt-free. The main indicator to watch in the upcoming result will be operating cashflow.
No comments yet
SPG - FY26 Annual Results
PYS - PaySauce FY26 Full Year Result and Annual Report
IFT - Infratil Full Year Results for the year ended 31 March 2026
May 27th Morning Report
RYM - FY26 marks significant year of progress
FPH reports strong revenue and profit growth for FY26
IFT - Infratil Full Year Results for the year ended 31 March 2026
PEB - Advancing Medicare Coverage Goals; Cost Contained
TRU - TruScreen Completes Oversubscribed Placement
EROAD Continues Transformation, Reports FY26 Results